135 related articles for article (PubMed ID: 3340440)
1. Effect of reconstituted pulmonary surfactant containing the 6000-dalton hydrophobic protein on lung compliance of prematurely delivered rabbit fetuses.
Yu SH; Wallace D; Bhavnani B; Enhorning G; Harding PG; Possmayer F
Pediatr Res; 1988 Jan; 23(1):23-30. PubMed ID: 3340440
[TBL] [Abstract][Full Text] [Related]
2. Hydrophobic surfactant-associated protein in whole lung surfactant and its importance for biophysical activity in lung surfactant extracts used for replacement therapy.
Whitsett JA; Ohning BL; Ross G; Meuth J; Weaver T; Holm BA; Shapiro DL; Notter RH
Pediatr Res; 1986 May; 20(5):460-7. PubMed ID: 3754957
[TBL] [Abstract][Full Text] [Related]
3. Immunologic identification of a pulmonary surfactant-associated protein of molecular weight = 6000 daltons.
Whitsett JA; Hull WM; Ohning B; Ross G; Weaver TE
Pediatr Res; 1986 Aug; 20(8):744-9. PubMed ID: 3526265
[TBL] [Abstract][Full Text] [Related]
4. Characterization and partial amino acid sequence of a low molecular weight surfactant protein.
Phelps DS; Smith LM; Taeusch HW
Am Rev Respir Dis; 1987 May; 135(5):1112-7. PubMed ID: 3579010
[TBL] [Abstract][Full Text] [Related]
5. The use of synthetic peptides in the formation of biophysically and biologically active pulmonary surfactants.
Revak SD; Merritt TA; Hallman M; Heldt G; La Polla RJ; Hoey K; Houghten RA; Cochrane CG
Pediatr Res; 1991 May; 29(5):460-5. PubMed ID: 1896249
[TBL] [Abstract][Full Text] [Related]
6. Phospholipid binding and biophysical activity of pulmonary surfactant-associated protein (SAP)-35 and its non-collagenous COOH-terminal domains.
Ross GF; Notter RH; Meuth J; Whitsett JA
J Biol Chem; 1986 Oct; 261(30):14283-91. PubMed ID: 3021734
[TBL] [Abstract][Full Text] [Related]
7. Comparative studies on the biophysical activities of the low-molecular-weight hydrophobic proteins purified from bovine pulmonary surfactant.
Yu SH; Possmayer F
Biochim Biophys Acta; 1988 Aug; 961(3):337-50. PubMed ID: 3401500
[TBL] [Abstract][Full Text] [Related]
8. Surfactant associated protein (SAP-35) in amniotic fluid from diabetic and nondiabetic pregnancies.
McMahan MJ; Mimouni F; Miodovnik M; Hull WM; Whitsett JA
Obstet Gynecol; 1987 Jul; 70(1):94-8. PubMed ID: 3601273
[TBL] [Abstract][Full Text] [Related]
9. Use of human surfactant low molecular weight apoproteins in the reconstitution of surfactant biologic activity.
Revak SD; Merritt TA; Degryse E; Stefani L; Courtney M; Hallman M; Cochrane CG
J Clin Invest; 1988 Mar; 81(3):826-33. PubMed ID: 3343343
[TBL] [Abstract][Full Text] [Related]
10. Surfactant apoprotein A modifies the inhibitory effect of plasma proteins on surfactant activity in vivo.
Yukitake K; Brown CL; Schlueter MA; Clements JA; Hawgood S
Pediatr Res; 1995 Jan; 37(1):21-5. PubMed ID: 7700729
[TBL] [Abstract][Full Text] [Related]
11. Low-molecular-weight hydrophobic proteins from bovine pulmonary surfactant.
Mathialagan N; Possmayer F
Biochim Biophys Acta; 1990 Jul; 1045(2):121-7. PubMed ID: 2378907
[TBL] [Abstract][Full Text] [Related]
12. Surfactant supplementation in the preterm rabbit: effects of applied volume on compliance and survival.
Metcalfe IL; Burgoyne R; Enhorning G
Pediatr Res; 1982 Oct; 16(10):834-9. PubMed ID: 6924203
[TBL] [Abstract][Full Text] [Related]
13. Lung function, surfactant apoprotein content, and level of PEEP in prematurely delivered rabbits.
Ogawa A; Brown CL; Schlueter MA; Benson BJ; Clements JA; Hawgood S
J Appl Physiol (1985); 1994 Oct; 77(4):1840-9. PubMed ID: 7836208
[TBL] [Abstract][Full Text] [Related]
14. Biophysical activity of synthetic phospholipids combined with purified lung surfactant 6000 dalton apoprotein.
Notter RH; Shapiro DL; Ohning B; Whitsett JA
Chem Phys Lipids; 1987 Jun; 44(1):1-17. PubMed ID: 3607971
[TBL] [Abstract][Full Text] [Related]
15. Synthesis of surfactant-associated protein, 35,000 daltons, in fetal lung.
Weaver TE; Ross G; Daugherty C; Whitsett JA
J Appl Physiol (1985); 1986 Aug; 61(2):694-700. PubMed ID: 2875055
[TBL] [Abstract][Full Text] [Related]
16. Surfactant-associated protein inhibits phospholipid secretion from type II cells.
Rice WR; Ross GF; Singleton FM; Dingle S; Whitsett JA
J Appl Physiol (1985); 1987 Aug; 63(2):692-8. PubMed ID: 3654429
[TBL] [Abstract][Full Text] [Related]
17. Changes in exogenous surfactant in ventilated preterm lamb lungs.
Ikegami M; Ueda T; Absolom D; Baxter C; Rider E; Jobe AH
Am Rev Respir Dis; 1993 Oct; 148(4 Pt 1):837-44. PubMed ID: 8214937
[TBL] [Abstract][Full Text] [Related]
18. Hyaline membrane disease and surfactant protein, SAP-35, in diabetes in pregnancy.
Nogee L; McMahan M; Whitsett JA
Am J Perinatol; 1988 Oct; 5(4):374-7. PubMed ID: 3048286
[TBL] [Abstract][Full Text] [Related]
19. Characterization of the small hydrophobic proteins associated with pulmonary surfactant.
Yu SH; Chung W; Olafson RW; Harding PG; Possmayer F
Biochim Biophys Acta; 1987 Oct; 921(3):437-48. PubMed ID: 3663690
[TBL] [Abstract][Full Text] [Related]
20. Glucocorticoid enhances surfactant proteolipid Phe and pVal synthesis and RNA in fetal lung.
Whitsett JA; Weaver TE; Clark JC; Sawtell N; Glasser SW; Korfhagen TR; Hull WM
J Biol Chem; 1987 Nov; 262(32):15618-23. PubMed ID: 2445738
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
